Cel-sci receives fda go-ahead for its confirmatory study of multikine in the treatment of head & neck cancer

Vienna, va.--(business wire)---- $cvm #multikine--cel-sci receives fda go-ahead for its confirmatory study of multikine in the treatment of head & neck cancer.

CVM Ratings Summary

CVM Quant Ranking